u/Sheero1986

Good news, bad news. Good news is the study on prevention was on the higher end of expected efficacy.

Bad news is they enrolled 500 more and because of that, topline data now expected third quarter 2026 instead of this June for December FDA approval.

We’re now looking at spring 2027.